Free Trial

Celsius (NASDAQ:CELH) Earns Buy Rating from Needham & Company LLC

Celsius logo with Consumer Staples background

Key Points

  • Analysts at Needham & Company have raised their price target for Celsius (NASDAQ:CELH) from $55.00 to $60.00, indicating a potential upside of 19.71% from its current price.
  • In recent months, several other brokerages have upgraded their ratings and price targets for Celsius, with an overall average target price now at $48.89.
  • Celsius reported a revenue increase of 83.9% year-over-year, achieving $739.30 million and exceeding consensus estimates of $632.13 million for the quarter.
  • Need Better Tools to Track Celsius? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Celsius (NASDAQ:CELH - Get Free Report)'s stock had its "buy" rating reiterated by investment analysts at Needham & Company LLC in a report released on Thursday, MarketBeat Ratings reports. They currently have a $60.00 target price on the stock, up from their prior target price of $55.00. Needham & Company LLC's target price suggests a potential upside of 15.50% from the company's current price.

A number of other research analysts also recently issued reports on the stock. Piper Sandler raised their price target on shares of Celsius from $44.00 to $45.00 and gave the stock an "overweight" rating in a research report on Wednesday, June 4th. Stifel Nicolaus raised their price target on shares of Celsius from $47.00 to $50.00 and gave the stock a "buy" rating in a research report on Tuesday, July 29th. Wall Street Zen upgraded shares of Celsius from a "sell" rating to a "hold" rating in a research report on Sunday, July 13th. Truist Financial lifted their price objective on shares of Celsius from $50.00 to $55.00 and gave the company a "buy" rating in a research report on Monday, July 14th. Finally, B. Riley lifted their price objective on shares of Celsius from $49.00 to $52.00 and gave the company a "buy" rating in a research report on Tuesday, July 29th. One research analyst has rated the stock with a sell rating, three have given a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $51.72.

Read Our Latest Stock Report on Celsius

Celsius Stock Up 3.7%

NASDAQ CELH traded up $1.83 during trading hours on Thursday, reaching $51.95. 10,291,968 shares of the company traded hands, compared to its average volume of 6,475,368. Celsius has a 12 month low of $21.10 and a 12 month high of $53.85. The company has a current ratio of 2.11, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $13.39 billion, a PE ratio of 140.41, a PEG ratio of 1.80 and a beta of 1.40. The company has a 50 day moving average of $44.51 and a two-hundred day moving average of $36.21.

Celsius (NASDAQ:CELH - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.47 EPS for the quarter, beating analysts' consensus estimates of $0.23 by $0.24. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The firm had revenue of $739.30 million for the quarter, compared to the consensus estimate of $632.13 million. During the same period in the prior year, the firm posted $0.28 EPS. The firm's revenue was up 83.9% compared to the same quarter last year. As a group, equities analysts expect that Celsius will post 0.89 earnings per share for the current year.

Insider Transactions at Celsius

In other news, CEO John Fieldly sold 143,167 shares of the company's stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $51.18, for a total transaction of $7,327,287.06. Following the transaction, the chief executive officer directly owned 895,410 shares of the company's stock, valued at $45,827,083.80. This represents a 13.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, major shareholder William H. Milmoe sold 300,000 shares of the company's stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $47.27, for a total value of $14,181,000.00. Following the sale, the insider owned 18,017,770 shares of the company's stock, valued at $851,699,987.90. This trade represents a 1.64% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,106,141 shares of company stock valued at $51,985,705 over the last ninety days. 2.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Westside Investment Management Inc. purchased a new position in shares of Celsius during the 1st quarter valued at about $32,000. Summit Securities Group LLC bought a new stake in shares of Celsius in the 1st quarter worth approximately $34,000. MassMutual Private Wealth & Trust FSB grew its position in shares of Celsius by 255.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company's stock worth $37,000 after buying an additional 750 shares during the last quarter. Hantz Financial Services Inc. grew its position in shares of Celsius by 1,476.0% in the 2nd quarter. Hantz Financial Services Inc. now owns 788 shares of the company's stock worth $37,000 after buying an additional 738 shares during the last quarter. Finally, UMB Bank n.a. lifted its stake in shares of Celsius by 145.0% in the 1st quarter. UMB Bank n.a. now owns 1,426 shares of the company's stock valued at $51,000 after purchasing an additional 844 shares during the period. Institutional investors own 60.95% of the company's stock.

About Celsius

(Get Free Report)

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

Further Reading

Analyst Recommendations for Celsius (NASDAQ:CELH)

Should You Invest $1,000 in Celsius Right Now?

Before you consider Celsius, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.

While Celsius currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines